Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa

Otieno, Mwanda W.; Banura, Cecily; Katongole-Mbidde, Edward; Johnson, John L.; Ghannoum, Mahmoud; Dowlati, Afshin; Renne, Rolf; Arts, Eric; Whalen, Christopher; Lederman, Michael M.; Remick, Scot C.
May 2002
JNCI: Journal of the National Cancer Institute;5/15/2002, Vol. 94 Issue 10, p718
Academic Journal
journal article
Non-Hodgkin's lymphoma (NHL) remains the second most common malignant complication in patients with human immunodeficiency virus (HIV) infection. As we enter the third decade of the acquired immunodeficiency syndrome (AIDS) epidemic, it is apparent that the evolution of antiretroviral therapy and the emergence of combination antiviral strategies have greatly affected the natural history of HIV infection and its neoplastic complications. For example, there may be a trend for declining incidence of AIDS-related lymphoma in the United States for the first time. However, in regions of the world where the burden of HIV infection is greatest, such as in East Africa, AIDS-related lymphoma is an increasing cause of morbidity and mortality. Treatment of lymphoma has evolved coincident with improvements in antiretroviral therapy. Infusional chemotherapy regimens may offer advantages over other regimens and schedules, but comparative trials have not been done. Clinical trial data are available on which to develop therapeutic strategies to treat this disease in East Africa where pragmatic approaches are needed. Both the differences in manifestations of HIV infection and the inherent difficulties in administering cytotoxic chemotherapy in this part of the world must be taken into consideration in planning therapeutic strategies. Improved understanding of the pathogenesis of HIV infection and lymphoma will likely yield improved therapeutic interventions as well.


Related Articles

  • HIV infection with Hodgkin's disease: The virus makes a difference. McNeil, Caroline // JNCI: Journal of the National Cancer Institute;06/04/97, Vol. 89 Issue 11, p754 

    Reports on the association between AIDS and Hodgkin's disease. Risk of cancer in people infected with HIV; Incidence of Hodgkin's disease in HIV cohorts; Differences with Hodgkin's disease with HIV and Hodgkin's disease without HIV. INSET: HIV-associated malignancies, by Charles S. Rabkin..

  • Thoracic Lymphadenopathy in HIV Patients: Spectrum of Disease and Differential Diagnosis. Fishman, Joel E.; Sagar, Meenor // AIDS Patient Care & STDs;Nov99, Vol. 13 Issue 11, p645 

    Focuses on intrathoracic lymphadenopathy (LAD) in HIV patients. Use of chest computed tomography records and CD4 counts in identifying HIV patients with LAD; Infectious and neoplastic causes of thoracic LAD; Distribution of malignancy; Incidence of seminoma in AIDS.

  • CAN WE TALK? Bodis, John // Body Politic;Feb85, Issue 111, p47 

    Presents an open letter about Hodgkin's disease or persistent lymphadenopathy syndrome and AIDS-related illness.

  • Rectal Hodgkin disease and the acquired immunodeficiency syndrome. Picard, Odile; De Gramont, Aimery; Krulik, Marcel; Gonzalez, Gustavo; Debray, Jacques; Cady, Jean; Picard, O; de Gramont, A; Krulik, M; Gonzalez, G; Debray, J; Cady, J // Annals of Internal Medicine;May87, Vol. 106 Issue 5, p775 

    A letter to the editor is presented in response to the article "Hodgkin's disease in homosexual men with generalized lymphodenapathy," by JL Schoeppel and colleagues in a 1985 issue, and the letter "Atypical Hodgkin's disease and the acquired immunodeficiency syndrome," by RG Scheib and...

  • Genetic basis of acquired immunodeficiency syndrome-related lymphomagenesis. Gaidano, Gianluca; Carbone, Antonino; Dalla-Favera, Riccardo // JNCI: Journal of the National Cancer Institute;05/06/98 Supplement Monograph 23, Vol. 90 Issue 9, p95 

    Provides information on a study which examines the process of the molecular pathogenesis of systemic acquired immunodeficiency syndrome (AIDS)-related non-Hodgkin's lymphomas (AIDS-NHL). Information on the host factors and the accumulation of genetic lesions within the tumor clone; Methodology...

  • EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda. Tumwine, Lynnette K.; Orem, Jackson; Kerchan, Patrick; Byarugaba, Wilson; Pileri, Stefano A. // Infectious Agents & Cancer;2010, Vol. 5, p12 

    Background: B cell non Hodgkin lymphomas account for the majority of lymphomas in Uganda. The commonest is endemic Burkitt lymphoma, followed by diffuse large-B-cell lymphoma (DLBCL). There has been an increase in incidence of malignant lymphoma since the onset of the HIV/AIDS pandemic. However,...

  • Cut chemo doses, study suggests.  // Drug Topics;6/16/97, Vol. 141 Issue 12, p7 

    Cites a multicenter study which concluded that AIDS patients with Hodgkins lymphoma can be as effectively treated with low doses of chemotherapy as with standard high doses.

  • AIDS increases stomach, esophageal cancer risks.  // Hem/Onc Today;11/10/2012, Vol. 13 Issue 21, p22 

    The article reports on the results of a study, which used the human immunodeficiency virus/acquired immune deficiency syndrome (AIDS) Cancer Match Study, claiming that AIDS patients are more likely than the general population to acquire stomach or esophageal carcinomas and non-Hodgkin's lymphomas.

  • Progressive Multifocal Leukoencephalopathy – Progress Made and Lessons Relearned. Greenlee, John E. // New England Journal of Medicine;05/07/98, Vol. 338 Issue 19, p1378 

    This editorial discusses multifocal leukoencephalopathy, an opportunistic demyelinating infection caused by the nonpathogenic papovavirus known as JC virus. The disease was initially identified as a rare complication of chronic lymphocytic leukemia and Hodgkin's disease. A discussion is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics